Christodoulos Kaoutzanis
Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 17 | 2023 | 96 | 11.140 |
Why?
| Surgical Wound Infection | 10 | 2023 | 292 | 4.200 |
Why?
| Perforator Flap | 7 | 2023 | 34 | 3.160 |
Why?
| Breast Implants | 3 | 2023 | 20 | 3.030 |
Why?
| Postoperative Complications | 20 | 2023 | 2500 | 2.650 |
Why?
| Breast Neoplasms | 13 | 2023 | 2112 | 2.400 |
Why?
| Mastectomy | 8 | 2023 | 126 | 2.130 |
Why?
| Free Tissue Flaps | 4 | 2023 | 47 | 1.960 |
Why?
| Cosmetic Techniques | 4 | 2019 | 19 | 1.920 |
Why?
| Esthetics | 8 | 2023 | 50 | 1.810 |
Why?
| Physical Therapy Modalities | 1 | 2023 | 293 | 1.640 |
Why?
| Breast Implantation | 2 | 2022 | 12 | 1.520 |
Why?
| Bariatric Surgery | | | 190 | NaN |
Why?
| Body Contouring | 2 | 2023 | 8 | 1.430 |
Why?
| Obesity, Morbid | | | 241 | NaN |
Why?
| Surgical Flaps | 2 | 2020 | 140 | 1.210 |
Why?
| Perioperative Care | 2 | 2019 | 151 | 1.120 |
Why?
| Sternum | 1 | 2023 | 25 | 1.110 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2023 | 21 | 1.110 |
Why?
| Sex Reassignment Surgery | 1 | 2020 | 7 | 1.100 |
Why?
| Sternotomy | 1 | 2023 | 24 | 1.090 |
Why?
| Cannabis | 2 | 2023 | 439 | 1.060 |
Why?
| Length of Stay | 6 | 2023 | 1133 | 1.030 |
Why?
| Imino Acids | 2 | 2015 | 5 | 0.940 |
Why?
| Breast | | | 149 | NaN |
Why?
| Implant Capsular Contracture | | | 5 | NaN |
Why?
| Cholecystitis, Acute | 2 | 2015 | 23 | 0.920 |
Why?
| Hypertrophy | | | 120 | NaN |
Why?
| Gender Dysphoria | | | 21 | NaN |
Why?
| Reoperation | 7 | 2020 | 555 | 0.900 |
Why?
| Patient Reported Outcome Measures | | | 359 | NaN |
Why?
| Retrospective Studies | 24 | 2023 | 14669 | 0.880 |
Why?
| Female | 42 | 2023 | 68562 | 0.870 |
Why?
| Suture Techniques | | | 121 | NaN |
Why?
| Mandibular Fractures | 1 | 2023 | 11 | 0.860 |
Why?
| Malocclusion | 1 | 2023 | 25 | 0.860 |
Why?
| Insurance | 1 | 2023 | 12 | 0.860 |
Why?
| Prosthesis-Related Infections | | | 80 | NaN |
Why?
| Humans | 64 | 2023 | 129706 | 0.850 |
Why?
| Skull Fractures | 1 | 2023 | 31 | 0.850 |
Why?
| Hernia, Ventral | 2 | 2013 | 23 | 0.850 |
Why?
| Middle Aged | 30 | 2023 | 31103 | 0.830 |
Why?
| Body Mass Index | 4 | 2019 | 2246 | 0.830 |
Why?
| Herniorrhaphy | 2 | 2013 | 60 | 0.820 |
Why?
| Nipples | 2 | 2020 | 7 | 0.800 |
Why?
| Vagina | | | 173 | NaN |
Why?
| Transplantation, Autologous | 4 | 2020 | 214 | 0.760 |
Why?
| Adipocytes, White | 1 | 2021 | 17 | 0.750 |
Why?
| Colorectal Surgery | 3 | 2017 | 22 | 0.750 |
Why?
| Hematoma | 2 | 2018 | 55 | 0.720 |
Why?
| Adult | 23 | 2023 | 35596 | 0.690 |
Why?
| Treatment Outcome | 18 | 2023 | 10299 | 0.690 |
Why?
| Analgesics, Opioid | 3 | 2023 | 917 | 0.650 |
Why?
| Preoperative Care | 3 | 2020 | 345 | 0.640 |
Why?
| Risk Factors | 14 | 2023 | 9832 | 0.640 |
Why?
| Incidence | 10 | 2023 | 2658 | 0.630 |
Why?
| Microsurgery | 1 | 2021 | 68 | 0.620 |
Why?
| Opioid-Related Disorders | 2 | 2023 | 502 | 0.620 |
Why?
| Standard of Care | 1 | 2018 | 70 | 0.570 |
Why?
| Lipectomy | 1 | 2017 | 7 | 0.570 |
Why?
| Pain, Postoperative | 5 | 2023 | 227 | 0.560 |
Why?
| Intestinal Perforation | 2 | 2014 | 44 | 0.520 |
Why?
| Epigastric Arteries | 5 | 2023 | 24 | 0.510 |
Why?
| Mental Disorders | | | 1025 | NaN |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 53 | 0.500 |
Why?
| Subcutaneous Fat | 1 | 2016 | 74 | 0.500 |
Why?
| 2-Propanol | 1 | 2015 | 20 | 0.490 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2016 | 80 | 0.490 |
Why?
| Iodine | 1 | 2015 | 21 | 0.490 |
Why?
| Chlorhexidine | 1 | 2015 | 24 | 0.490 |
Why?
| Acrylic Resins | 1 | 2015 | 45 | 0.480 |
Why?
| Quality of Life | 2 | 2022 | 2712 | 0.480 |
Why?
| Skin Neoplasms | 2 | 2013 | 829 | 0.460 |
Why?
| Laparoscopy | 3 | 2015 | 456 | 0.460 |
Why?
| Young Adult | 10 | 2018 | 12363 | 0.460 |
Why?
| Male | 34 | 2023 | 63544 | 0.450 |
Why?
| Anti-Bacterial Agents | | | 1719 | NaN |
Why?
| Risk Assessment | 6 | 2019 | 3297 | 0.440 |
Why?
| Macrophages | 1 | 2021 | 1459 | 0.430 |
Why?
| Vascular Surgical Procedures | 2 | 2021 | 295 | 0.430 |
Why?
| Pancreatic Neoplasms | 2 | 2013 | 881 | 0.430 |
Why?
| Venous Thromboembolism | 3 | 2023 | 273 | 0.430 |
Why?
| Hemorrhoidectomy | 1 | 2013 | 1 | 0.430 |
Why?
| Intestine, Small | 2 | 2014 | 140 | 0.430 |
Why?
| Rectovaginal Fistula | 1 | 2013 | 9 | 0.430 |
Why?
| Meckel Diverticulum | 1 | 2013 | 3 | 0.420 |
Why?
| Prospective Studies | 10 | 2023 | 7131 | 0.420 |
Why?
| Foreign-Body Migration | 1 | 2013 | 35 | 0.410 |
Why?
| Fishes | 1 | 2013 | 93 | 0.400 |
Why?
| Ileum | 1 | 2013 | 113 | 0.390 |
Why?
| Endocarditis, Bacterial | 1 | 2012 | 43 | 0.390 |
Why?
| Smoking | 1 | 2019 | 1507 | 0.370 |
Why?
| Acellular Dermis | 2 | 2022 | 12 | 0.360 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2011 | 107 | 0.360 |
Why?
| Aged | 18 | 2018 | 22113 | 0.360 |
Why?
| Hepatic Veins | 1 | 2010 | 31 | 0.350 |
Why?
| Ethanol | 1 | 2015 | 578 | 0.350 |
Why?
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2010 | 24 | 0.350 |
Why?
| Rhinoplasty | 2 | 2023 | 27 | 0.350 |
Why?
| Aged, 80 and over | 7 | 2018 | 7074 | 0.350 |
Why?
| Streptococcal Infections | 1 | 2012 | 146 | 0.350 |
Why?
| Transgender Persons | 1 | 2022 | 174 | 0.350 |
Why?
| Vena Cava, Inferior | 1 | 2010 | 68 | 0.340 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2012 | 198 | 0.330 |
Why?
| Vascular System Injuries | 1 | 2010 | 73 | 0.330 |
Why?
| United States | 7 | 2023 | 14078 | 0.330 |
Why?
| Multivariate Analysis | 3 | 2018 | 1507 | 0.320 |
Why?
| Foreign Bodies | 1 | 2010 | 102 | 0.320 |
Why?
| Sciatic Nerve | 2 | 2020 | 59 | 0.320 |
Why?
| Sex Factors | 4 | 2019 | 1952 | 0.320 |
Why?
| Diffusion Tensor Imaging | 2 | 2020 | 68 | 0.320 |
Why?
| Adenocarcinoma | 2 | 2013 | 895 | 0.320 |
Why?
| Wound Healing | 2 | 2023 | 310 | 0.310 |
Why?
| Lymph Nodes | 1 | 2011 | 458 | 0.310 |
Why?
| Cardiopulmonary Bypass | 1 | 2010 | 193 | 0.310 |
Why?
| Hospitalization | 2 | 2017 | 2091 | 0.310 |
Why?
| Pregnancy Complications, Infectious | 1 | 2012 | 334 | 0.300 |
Why?
| Umbilicus | 2 | 2022 | 16 | 0.300 |
Why?
| Aortic Valve | 1 | 2012 | 425 | 0.300 |
Why?
| Logistic Models | 3 | 2018 | 1980 | 0.290 |
Why?
| Skin | 1 | 2013 | 737 | 0.290 |
Why?
| Neoplasm Staging | 1 | 2011 | 1286 | 0.290 |
Why?
| Follow-Up Studies | 5 | 2019 | 4939 | 0.280 |
Why?
| Patient Acceptance of Health Care | 1 | 2023 | 776 | 0.280 |
Why?
| Wounds, Nonpenetrating | 1 | 2010 | 287 | 0.280 |
Why?
| Surgical Wound Dehiscence | 1 | 2023 | 22 | 0.280 |
Why?
| Tissue and Organ Harvesting | 2 | 2020 | 75 | 0.260 |
Why?
| Rectum | 3 | 2015 | 166 | 0.250 |
Why?
| Ultrasonography | 3 | 2015 | 729 | 0.250 |
Why?
| Chi-Square Distribution | 2 | 2017 | 517 | 0.250 |
Why?
| Patient Satisfaction | 2 | 2023 | 642 | 0.240 |
Why?
| Age Factors | 5 | 2019 | 3145 | 0.240 |
Why?
| Adolescent | 9 | 2018 | 20355 | 0.240 |
Why?
| Silicone Gels | | | 4 | NaN |
Why?
| Cross-Sectional Studies | 1 | 2023 | 5050 | 0.230 |
Why?
| Proof of Concept Study | | | 63 | NaN |
Why?
| Radionuclide Imaging | 2 | 2015 | 127 | 0.230 |
Why?
| Melanoma | 1 | 2011 | 735 | 0.230 |
Why?
| Pectoralis Muscles | | | 17 | NaN |
Why?
| Gynecologic Surgical Procedures | | | 54 | NaN |
Why?
| Databases, Factual | 4 | 2017 | 1297 | 0.220 |
Why?
| Odds Ratio | 2 | 2017 | 1025 | 0.220 |
Why?
| Time Factors | 5 | 2019 | 6593 | 0.220 |
Why?
| Body Dysmorphic Disorders | 1 | 2023 | 11 | 0.220 |
Why?
| Hydrocodone | 1 | 2023 | 17 | 0.220 |
Why?
| Surgery, Plastic | 1 | 2023 | 31 | 0.220 |
Why?
| Rhytidoplasty | 1 | 2023 | 5 | 0.210 |
Why?
| Blepharoplasty | 1 | 2023 | 7 | 0.210 |
Why?
| Colon | 2 | 2015 | 247 | 0.210 |
Why?
| Tobacco Use | 1 | 2023 | 59 | 0.210 |
Why?
| Mandible | 1 | 2023 | 64 | 0.210 |
Why?
| Operative Time | 4 | 2019 | 122 | 0.210 |
Why?
| Leg Injuries | 1 | 2023 | 28 | 0.210 |
Why?
| Enoxaparin | 1 | 2023 | 59 | 0.200 |
Why?
| Fat Necrosis | 1 | 2022 | 8 | 0.200 |
Why?
| Tennessee | 2 | 2022 | 45 | 0.200 |
Why?
| Nerve Regeneration | 2 | 2020 | 61 | 0.190 |
Why?
| Anticoagulants | 2 | 2023 | 623 | 0.190 |
Why?
| Colonic Neoplasms | | | 234 | NaN |
Why?
| Cicatrix | 1 | 2022 | 58 | 0.190 |
Why?
| Insurance, Health | 1 | 2023 | 270 | 0.180 |
Why?
| Surveys and Questionnaires | 3 | 2023 | 5396 | 0.180 |
Why?
| Hypotension | 1 | 2022 | 124 | 0.180 |
Why?
| Emergency Service, Hospital | 3 | 2017 | 2044 | 0.180 |
Why?
| Lower Extremity | 2 | 2023 | 404 | 0.180 |
Why?
| Biopsy | 2 | 2016 | 1098 | 0.180 |
Why?
| Necrosis | 1 | 2021 | 234 | 0.170 |
Why?
| Vulva | 1 | 2020 | 24 | 0.170 |
Why?
| Penis | 1 | 2020 | 37 | 0.170 |
Why?
| Scrotum | 1 | 2020 | 25 | 0.170 |
Why?
| Transsexualism | 1 | 2020 | 20 | 0.170 |
Why?
| Outpatients | 1 | 2023 | 366 | 0.170 |
Why?
| Diagnosis, Differential | 3 | 2013 | 1442 | 0.170 |
Why?
| Tissue Expansion | 1 | 2019 | 10 | 0.170 |
Why?
| Solutions | 1 | 2019 | 147 | 0.160 |
Why?
| Administration, Topical | 2 | 2019 | 148 | 0.160 |
Why?
| Cohort Studies | 1 | 2011 | 5410 | 0.160 |
Why?
| Antifungal Agents | 1 | 2019 | 132 | 0.160 |
Why?
| Referral and Consultation | | | 731 | NaN |
Why?
| Rectal Diseases | 2 | 2015 | 19 | 0.150 |
Why?
| Meningomyelocele | 1 | 2019 | 59 | 0.150 |
Why?
| Peripheral Nerve Injuries | 1 | 2018 | 35 | 0.150 |
Why?
| Datasets as Topic | 1 | 2019 | 108 | 0.150 |
Why?
| Colonic Diseases | 2 | 2015 | 31 | 0.150 |
Why?
| Sepsis | 2 | 2015 | 566 | 0.150 |
Why?
| Tomography, X-Ray Computed | 3 | 2013 | 2539 | 0.150 |
Why?
| Ovarian Neoplasms | 1 | 2023 | 475 | 0.150 |
Why?
| Obesity | 1 | 2017 | 2851 | 0.140 |
Why?
| Surgeons | 1 | 2022 | 279 | 0.140 |
Why?
| Infusions, Parenteral | 1 | 2017 | 39 | 0.140 |
Why?
| Perception | 1 | 2020 | 339 | 0.140 |
Why?
| Analgesia, Epidural | 1 | 2017 | 22 | 0.140 |
Why?
| Hospital Costs | 1 | 2018 | 117 | 0.140 |
Why?
| Axons | 1 | 2018 | 181 | 0.140 |
Why?
| Biofilms | 1 | 2019 | 248 | 0.140 |
Why?
| Anti-Infective Agents | 1 | 2019 | 249 | 0.130 |
Why?
| Adipose Tissue | 1 | 2020 | 588 | 0.130 |
Why?
| Linear Models | 2 | 2015 | 823 | 0.130 |
Why?
| Child | 5 | 2021 | 20963 | 0.130 |
Why?
| Analgesics | 1 | 2017 | 174 | 0.130 |
Why?
| Anastomotic Leak | 1 | 2015 | 38 | 0.120 |
Why?
| Physicians | 1 | 2023 | 852 | 0.120 |
Why?
| Patient Admission | 1 | 2016 | 185 | 0.120 |
Why?
| Sensitivity and Specificity | 2 | 2019 | 1849 | 0.120 |
Why?
| Practice Patterns, Physicians' | 1 | 2023 | 1287 | 0.120 |
Why?
| Jejunal Diseases | 1 | 2014 | 7 | 0.110 |
Why?
| Breast Diseases | 1 | 2014 | 22 | 0.110 |
Why?
| Diverticulum | 1 | 2014 | 11 | 0.110 |
Why?
| Pain Management | 1 | 2017 | 327 | 0.110 |
Why?
| Fistula | 1 | 2014 | 34 | 0.110 |
Why?
| Mammary Glands, Human | 1 | 2014 | 61 | 0.110 |
Why?
| Cholecystectomy | 1 | 2014 | 60 | 0.110 |
Why?
| Abscess | 1 | 2014 | 73 | 0.110 |
Why?
| Hemorrhoids | 1 | 2013 | 2 | 0.110 |
Why?
| Robotic Surgical Procedures | 1 | 2015 | 108 | 0.110 |
Why?
| Liver Transplantation | 1 | 2021 | 814 | 0.110 |
Why?
| Ileostomy | 1 | 2013 | 20 | 0.110 |
Why?
| Thigh | 1 | 2013 | 54 | 0.100 |
Why?
| Viridans Streptococci | 1 | 2012 | 6 | 0.100 |
Why?
| Streptococcus anginosus | 1 | 2012 | 9 | 0.100 |
Why?
| Patient Selection | 1 | 2016 | 685 | 0.100 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1981 | 0.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 340 | 0.100 |
Why?
| Aortic Valve Insufficiency | 1 | 2012 | 47 | 0.100 |
Why?
| Drug Therapy, Combination | 1 | 2015 | 1024 | 0.100 |
Why?
| Telemedicine | 1 | 2021 | 792 | 0.100 |
Why?
| Lymphoscintigraphy | 1 | 2011 | 9 | 0.100 |
Why?
| Barium Sulfate | 1 | 2011 | 15 | 0.100 |
Why?
| Hyperglycemia | 1 | 2015 | 322 | 0.100 |
Why?
| Pancreaticoduodenectomy | 1 | 2013 | 159 | 0.090 |
Why?
| Intraoperative Care | 1 | 2011 | 44 | 0.090 |
Why?
| Gamma Rays | 1 | 2011 | 52 | 0.090 |
Why?
| Wounds and Injuries | 1 | 2019 | 808 | 0.090 |
Why?
| Sensation | 1 | 2011 | 49 | 0.090 |
Why?
| Pharynx | 1 | 2011 | 56 | 0.090 |
Why?
| Clinical Protocols | 2 | 2023 | 259 | 0.090 |
Why?
| Phlebography | 1 | 2010 | 36 | 0.090 |
Why?
| Cooking and Eating Utensils | 1 | 2010 | 5 | 0.090 |
Why?
| Pelvis | 1 | 2011 | 102 | 0.090 |
Why?
| Lung Diseases | 1 | 2017 | 757 | 0.090 |
Why?
| Lymphatic Metastasis | 1 | 2011 | 312 | 0.090 |
Why?
| Lymph Node Excision | 1 | 2011 | 166 | 0.090 |
Why?
| Registries | 1 | 2019 | 2008 | 0.090 |
Why?
| Diabetes Mellitus, Type 2 | | | 2424 | NaN |
Why?
| Neoplasm Recurrence, Local | 1 | 2016 | 952 | 0.080 |
Why?
| Laparotomy | 1 | 2010 | 109 | 0.080 |
Why?
| Disease-Free Survival | 1 | 2011 | 658 | 0.080 |
Why?
| Deglutition Disorders | 1 | 2011 | 129 | 0.080 |
Why?
| Patient Readmission | 1 | 2015 | 675 | 0.080 |
Why?
| Graft Rejection | 1 | 2013 | 569 | 0.080 |
Why?
| Accidents, Traffic | 1 | 2010 | 192 | 0.080 |
Why?
| Contrast Media | 1 | 2011 | 388 | 0.080 |
Why?
| Oxygen | 1 | 2013 | 921 | 0.080 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 207 | 0.080 |
Why?
| Intensive Care Units | 1 | 2013 | 738 | 0.080 |
Why?
| Survival Analysis | 1 | 2011 | 1297 | 0.070 |
Why?
| Anastomosis, Surgical | 2 | 2021 | 151 | 0.070 |
Why?
| Coronary Disease | 1 | 2009 | 389 | 0.070 |
Why?
| Child, Preschool | 2 | 2017 | 10565 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2021 | 3054 | 0.060 |
Why?
| Spain | | | 38 | NaN |
Why?
| Netherlands | | | 77 | NaN |
Why?
| Recovery of Function | 2 | 2020 | 643 | 0.060 |
Why?
| Canada | | | 355 | NaN |
Why?
| Abdominal Muscles | 1 | 2023 | 4 | 0.050 |
Why?
| Eyebrows | 1 | 2023 | 2 | 0.050 |
Why?
| Abdomen | | | 116 | NaN |
Why?
| Information Seeking Behavior | 1 | 2023 | 35 | 0.050 |
Why?
| Salpingo-oophorectomy | 1 | 2023 | 17 | 0.050 |
Why?
| Bupivacaine | 1 | 2023 | 32 | 0.050 |
Why?
| Prognosis | 1 | 2011 | 3801 | 0.050 |
Why?
| Narcotics | 1 | 2023 | 47 | 0.050 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1632 | 0.050 |
Why?
| Chemoprevention | 1 | 2023 | 88 | 0.050 |
Why?
| Limb Salvage | 1 | 2023 | 59 | 0.050 |
Why?
| Ovariectomy | 1 | 2023 | 135 | 0.050 |
Why?
| Anesthetics, Local | 1 | 2023 | 85 | 0.050 |
Why?
| Seroma | 1 | 2022 | 3 | 0.050 |
Why?
| Postoperative Period | 1 | 2023 | 320 | 0.050 |
Why?
| Morphine | 1 | 2023 | 134 | 0.050 |
Why?
| Liposomes | 1 | 2023 | 163 | 0.050 |
Why?
| Incidental Findings | 1 | 2022 | 80 | 0.050 |
Why?
| Computed Tomography Angiography | 1 | 2022 | 117 | 0.050 |
Why?
| Psychometrics | | | 681 | NaN |
Why?
| Hepatic Artery | 1 | 2021 | 58 | 0.040 |
Why?
| Crush Injuries | 1 | 2020 | 9 | 0.040 |
Why?
| Pregnancy | 1 | 2012 | 6274 | 0.040 |
Why?
| Tissue Expansion Devices | 1 | 2019 | 5 | 0.040 |
Why?
| Gram-Positive Bacteria | 1 | 2019 | 45 | 0.040 |
Why?
| Dopamine | 1 | 2022 | 281 | 0.040 |
Why?
| Gram-Negative Bacteria | 1 | 2019 | 70 | 0.040 |
Why?
| Animals | 3 | 2020 | 34733 | 0.040 |
Why?
| Office Visits | 1 | 2019 | 85 | 0.040 |
Why?
| Skin Transplantation | 1 | 2019 | 87 | 0.040 |
Why?
| Equipment Design | 1 | 2020 | 527 | 0.040 |
Why?
| Living Donors | 1 | 2021 | 299 | 0.040 |
Why?
| Rabbits | 1 | 2018 | 758 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2018 | 559 | 0.030 |
Why?
| Pain Measurement | 1 | 2017 | 497 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2020 | 2314 | 0.030 |
Why?
| Propensity Score | 1 | 2015 | 263 | 0.030 |
Why?
| Diabetes Complications | 1 | 2015 | 227 | 0.030 |
Why?
| Hospital Rapid Response Team | 1 | 2013 | 18 | 0.030 |
Why?
| Chronic Disease | 1 | 2019 | 1721 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2013 | 268 | 0.020 |
Why?
| Radiography | 1 | 2014 | 863 | 0.020 |
Why?
| Recurrence | 1 | 2014 | 1016 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2020 | 4016 | 0.020 |
Why?
| Renin-Angiotensin System | 1 | 2009 | 80 | 0.020 |
Why?
| Administration, Oral | 1 | 2011 | 790 | 0.020 |
Why?
| Societies, Medical | 1 | 2013 | 763 | 0.020 |
Why?
| Infant, Newborn | 1 | 2019 | 5752 | 0.020 |
Why?
| Regression Analysis | 1 | 2009 | 992 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2612 | 0.020 |
Why?
| Algorithms | 1 | 2013 | 1632 | 0.020 |
Why?
| Cardiac Catheterization | 1 | 2009 | 583 | 0.020 |
Why?
| Blood Glucose | 1 | 2015 | 2090 | 0.020 |
Why?
| Infant | 1 | 2019 | 9097 | 0.020 |
Why?
| Survival Rate | 1 | 2009 | 1894 | 0.010 |
Why?
| Stroke | 1 | 2009 | 1111 | 0.010 |
Why?
|
|
Kaoutzanis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|